U.S. Medicare outlook improves as healthcare costs ease
By David Lawder and Margaret Chadbourn WASHINGTON (Reuters) - Slower growth in U.S. healthcare costs improved the budget outlook for...
Read More »By David Lawder and Margaret Chadbourn WASHINGTON (Reuters) - Slower growth in U.S. healthcare costs improved the budget outlook for...
Read More »
PARIS (Reuters) - France will ban electronic cigarette smoking in public places by imposing the same curbs enforced since 2007 to co...
Read More »By Sumeet Chatterjee and Kaustubh Kulkarni MUMBAI (Reuters) - India's Sun Pharmaceutical Industries Ltd is in talks to buy Sweden's ...
Read More »By Fredrik Dahl VIENNA (Reuters) - The evacuation of tens of thousands of people helped prevent rising cancer rates and other health...
Read More »GENEVA (Reuters) - Three more people have died in Saudi Arabia from the new SARS-like coronavirus, bringing the worldwide death toll...
Read More »LONDON (Reuters) - Use of an epilepsy drug developed by GlaxoSmithKline and Valeant Pharmaceuticals should be restricted to patients...
Read More »By Julie Steenhuysen and Deena Beasley CHICAGO/LOS ANGELES (Reuters) - Diagnosed with advanced lung cancer over a year ago, Gabe Tar...
Read More »LONDON (Reuters) - Britain's healthcare cost watchdog NICE is recommending a new eye drug from Bayer and Regeneron, after a price di...
Read More »By Andrew M. Seaman NEW YORK (Reuters Health) - Popular smoking cessation treatments - such as nicotine replacements and antidepress...
Read More »LONDON (Reuters) - There are no benefits from giving patients with severe flu a double dose of Roche's drug Tamiflu, despite calls b...
Read More »